Award
Delivery Order #SPE2DR26FCFU5
Delivery Order for XOLAIR Injection from DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$6,989.76
Ceiling
$6,989.76
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 27, 2026
Identifier
SPE2DR26FCFU5
NAICS
424210
This award represents a delivery order contract issued under an existing indefinite delivery vehicle with DMS Pharmaceutical Group Inc., a recognized supplier of pharmaceutical products to federal health programs. The contract specifically procures XOLAIR 300 MG/2 ML autoinjectors, a critical medication utilized in specialized medical treatments. Its significance lies in supporting ongoing government health initiatives by ensuring timely access to essential pharmaceuticals. The scope includes delivering the specified autoinjectors within a short, scheduled timeframe, emphasizing reliable supply chain execution. This delivery order continues the utilization of a competitively awarded contracting vehicle that fosters fair provider selection. The performance period of this order spans a few weeks, reinforcing the contract's role in prompt pharmaceutical provisioning for public health services.
Description
4571114250!XOLAIR 300 MG/2 ML AUTOINJECT 2ML